Shaun Cho, MD
Cardiac Electrophysiology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · Physician Services at El Camino Hospital · Stanford Health Care
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cho’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A68634 · Current
Licensed to practise in California · since 1999 · expires 2027-06-30 · Cornell University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$314,308
Medicare paid this office $314,308 for 1,969 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 342 | $93,940 | $162 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 60 | $30,987 | $500 |
| New patient visit (60+ min) | 151 | $29,749 | $197 |
| Return visit (30+ min) | 143 | $17,264 | $105 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 75 | $14,579 | $57 |
See all 26 services
| Long return visit (40+ min) | 342 | $93,940 | $162 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 60 | $30,987 | $500 |
| New patient visit (60+ min) | 151 | $29,749 | $197 |
| Return visit (30+ min) | 143 | $17,264 | $105 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 75 | $14,579 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 454 | $13,650 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 363 | $11,997 | $24 |
| Programming of dual lead pacemaker system | 105 | $11,804 | $78 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $9,452 | $255 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,846 | $680 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 630 | $5,605 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 382 | $5,463 | $13 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,914 | $447 |
| External shock to heart to regulate heart beat | 44 | $4,691 | $94 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 217 | $4,131 | $15 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 94 | $3,858 | $29 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,542 | $295 |
| Programming of dual lead implantable defibrillator system | 21 | $3,037 | $98 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,908 | $75 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 118 | $2,678 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,027 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,024 | $156 |
| Heart rhythm recording of continous external ekg over 8-15 days | 117 | $1,524 | $13 |
| Programming of heart rhythm stimulation after drug infusion | 12 | $790 | $61 |
| Programming of dual lead pacemaker system | 17 | $514 | $30 |
| Blood test, clotting time | 15 | $84 | $4 |
Procedures Medicare counted
| Pacemaker insertion or repair | 13 | More than 64% of doctors who do this |
Who their Medicare patients are
1,969 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 26% · Women 46% · Also on Medicaid 13% · Health risk score 1.53. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 55% · Coronary heart disease 39% · Heart failure 32% · Chronic kidney disease 31% · Diabetes 28% · Cancer 21% · Depression 19% · COPD 13% · Dementia 13% · Stroke 13%.
The office billed $1,401,831, Medicare allowed $416,103 and paid $314,308; for 4,796 services of 61 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,969 | 4,796 | 79 | 1.53 | $1,401,831 | $314,308 |
| 2023 | 1,688 | 4,158 | 79 | 1.38 | $1,331,711 | $311,784 |
| 2022 | 1,886 | 4,100 | 79 | 1.47 | $1,144,190 | $283,070 |
| 2021 | 1,501 | 3,064 | 79 | 1.45 | $960,840 | $243,590 |
| 2020 | 1,362 | 2,787 | 78 | 1.52 | $816,502 | $201,669 |
| 2019 | 1,747 | 3,626 | 78 | 1.55 | $972,924 | $226,712 |
| 2018 | 1,629 | 3,191 | 77 | 1.42 | $964,915 | $232,864 |
| 2017 | 1,597 | 3,037 | 77 | 1.39 | $852,946 | $214,773 |
| 2016 | 1,381 | 2,615 | 77 | 1.41 | $726,808 | $188,011 |
| 2015 | 1,185 | 2,497 | 76 | 1.29 | $820,586 | $218,236 |
| 2014 | 1,066 | 2,063 | 77 | 1.13 | $651,970 | $160,610 |
| 2013 | 1,031 | 2,077 | 77 | 1.24 | $659,211 | $153,135 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 29 services
| Long return visit (40+ min) | 269 | $70,219 | $159 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 78 | $41,298 | $529 |
| Return visit (30+ min) | 240 | $33,537 | $111 |
| New patient visit (60+ min) | 132 | $26,729 | $202 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 47 | $14,555 | $260 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 18 | $12,770 | $709 |
| Programming of dual lead pacemaker system | 99 | $12,025 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 390 | $11,920 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 307 | $10,078 | $24 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $9,041 | $452 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 59 | $7,896 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 391 | $5,653 | $13 |
| Hospital discharge day management, 30 minutes or less | 61 | $4,631 | $75 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 15 | $4,105 | $241 |
| External shock to heart to regulate heart beat | 33 | $3,827 | $98 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,685 | $307 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 88 | $3,567 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 395 | $3,488 | $7 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 60 | $3,027 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 110 | $2,599 | $23 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,399 | $160 |
| Programming of dual lead implantable defibrillator system | 15 | $1,779 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,646 | $110 |
| Programming of single lead pacemaker system | 15 | $1,431 | $62 |
| Heart rhythm recording of continous external ekg over 8-15 days | 107 | $1,421 | $13 |
| Programming of heart rhythm stimulation after drug infusion | 12 | $1,041 | $80 |
| Programming of dual lead pacemaker system | 24 | $868 | $35 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $468 | $22 |
| Blood test, clotting time | 38 | $298 | $4 |
2022: 28 services
| Long return visit (40+ min) | 209 | $56,325 | $165 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 57 | $36,810 | $624 |
| Return visit (30+ min) | 250 | $36,590 | $111 |
| New patient visit (60+ min) | 123 | $24,616 | $200 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 17 | $12,428 | $731 |
| Programming of dual lead pacemaker system | 80 | $10,613 | $84 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $10,285 | $467 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 308 | $9,458 | $24 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $9,112 | $268 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 238 | $7,653 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 725 | $6,854 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 418 | $5,773 | $13 |
| Insertion of permanent leadless pacemaker using imaging guidance | 11 | $4,818 | $438 |
| External shock to heart to regulate heart beat | 22 | $2,992 | $100 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 71 | $2,905 | $32 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,544 | $159 |
| Hospital observation care on day of discharge | 34 | $2,411 | $67 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 46 | $2,253 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 85 | $2,083 | $24 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 45 | $2,075 | $23 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,019 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,591 | $88 |
| Programming of dual lead implantable defibrillator system | 13 | $1,529 | $96 |
| Heart rhythm recording of continous external ekg over 8-15 days | 82 | $1,256 | $15 |
| Programming of dual lead pacemaker system | 20 | $777 | $35 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 30 | $673 | $21 |
| Blood test, clotting time | 45 | $407 | $4 |
| Anticoagulant management of patient taking warfarin | 27 | $330 | $8 |
2021: 28 services
| Long return visit (40+ min) | 170 | $39,332 | $153 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 62 | $34,033 | $549 |
| Return visit (30+ min) | 215 | $29,179 | $111 |
| New patient visit (60+ min) | 101 | $20,881 | $207 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 75 | $12,487 | $166 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $11,762 | $346 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $8,936 | $745 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $7,782 | $458 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 229 | $6,401 | $23 |
| Programming of dual lead pacemaker system | 61 | $5,906 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 363 | $5,244 | $14 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 64 | $4,115 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 118 | $3,344 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,333 | $185 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 345 | $3,175 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 75 | $2,884 | $30 |
| Hospital observation care on day of discharge | 42 | $2,834 | $67 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 91 | $2,373 | $25 |
| Programming of dual lead implantable defibrillator system | 15 | $1,647 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,634 | $91 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 48 | $1,507 | $19 |
| Heart rhythm recording of continous external ekg over 8-15 days | 81 | $1,399 | $16 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,369 | $105 |
| External shock to heart to regulate heart beat | 12 | $1,326 | $102 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 37 | $1,188 | $22 |
| Programming of dual lead pacemaker system | 17 | $612 | $36 |
| Blood test, clotting time | 57 | $579 | $4 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $151 | $14 |
2020: 31 services
| Return visit (30+ min) | 248 | $37,501 | $94 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 38 | $25,235 | $664 |
| New patient visit (60+ min) | 74 | $14,358 | $194 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 18 | $13,000 | $684 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 56 | $11,655 | $201 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 21 | $9,919 | $472 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 25 | $8,718 | $349 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 226 | $7,116 | $26 |
| Programming of dual lead pacemaker system | 61 | $5,124 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 295 | $4,751 | $15 |
| Long return visit (40+ min) | 30 | $4,517 | $141 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 149 | $4,221 | $26 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,916 | $186 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 370 | $3,658 | $8 |
| Short return visit (20+ min) | 51 | $3,509 | $66 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 43 | $3,308 | $77 |
| Hospital observation care on day of discharge | 40 | $2,850 | $68 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 74 | $2,630 | $30 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,950 | $103 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 17 | $1,847 | $103 |
| New patient visit (45+ min) | 13 | $1,615 | $124 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 59 | $1,475 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 37 | $1,332 | $20 |
| External ekg recording for more than 48 hours up to 21 days | 46 | $1,286 | $27 |
| External shock to heart to regulate heart beat | 12 | $1,255 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $947 | $63 |
| Programming of dual lead pacemaker system | 18 | $703 | $37 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 22 | $617 | $25 |
| Blood test, clotting time | 63 | $489 | $4 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 12 | $278 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $137 | $11 |
2019: 33 services
| Return visit (30+ min) | 286 | $46,537 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 44 | $26,170 | $582 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 25 | $18,366 | $706 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 70 | $13,798 | $192 |
| New patient visit (60+ min) | 57 | $11,080 | $194 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $8,212 | $456 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 509 | $8,198 | $15 |
| New patient visit (45+ min) | 51 | $6,578 | $129 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 19 | $6,566 | $328 |
| Programming of dual lead pacemaker system | 79 | $6,132 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 556 | $5,167 | $8 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 169 | $4,627 | $23 |
| Hospital observation care on day of discharge | 57 | $3,865 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 121 | $3,320 | $24 |
| Short return visit (20+ min) | 52 | $3,197 | $60 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 45 | $3,065 | $67 |
| External ekg recording for more than 48 hours up to 21 days | 109 | $3,060 | $28 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 81 | $2,979 | $22 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 26 | $2,722 | $101 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 109 | $2,702 | $24 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,580 | $184 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $1,863 | $133 |
| Programming of dual lead implantable defibrillator system | 16 | $1,821 | $79 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 46 | $1,699 | $31 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,449 | $80 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 33 | $1,439 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,147 | $64 |
| Blood test, clotting time | 105 | $898 | $4 |
| Programming of single lead pacemaker system | 13 | $835 | $52 |
| Programming of dual lead pacemaker system | 22 | $820 | $36 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $292 | $16 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 18 | $224 | $10 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $200 | $11 |
2018: 31 services
| Return visit (30+ min) | 257 | $47,486 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 61 | $34,874 | $572 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 75 | $13,737 | $183 |
| New patient visit (45+ min) | 87 | $12,760 | $147 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $11,178 | $349 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 667 | $10,772 | $15 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $8,851 | $443 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $8,244 | $589 |
| Programming of dual lead pacemaker system | 81 | $5,487 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 176 | $5,393 | $26 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 13 | $4,181 | $322 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 61 | $4,135 | $68 |
| Hospital observation care on day of discharge | 64 | $4,078 | $64 |
| Short return visit (20+ min) | 70 | $3,838 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 380 | $3,412 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,911 | $182 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 38 | $2,110 | $47 |
| New patient visit (60+ min) | 11 | $2,105 | $191 |
| External shock to heart to regulate heart beat | 17 | $2,018 | $101 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 83 | $1,959 | $23 |
| Programming of heart rhythm stimulation after drug infusion | 14 | $1,715 | $123 |
| External ekg recording for more than 48 hours up to 21 days | 61 | $1,679 | $26 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 20 | $1,678 | $84 |
| Programming of dual lead implantable defibrillator system | 20 | $1,626 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 40 | $1,542 | $33 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 61 | $1,469 | $23 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 15 | $1,280 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,046 | $65 |
| Programming of dual lead pacemaker system | 24 | $874 | $35 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 15 | $232 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $165 | $11 |
2017: 32 services
| Return visit (30+ min) | 221 | $40,311 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 43 | $22,416 | $509 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 70 | $16,440 | $228 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 24 | $15,646 | $626 |
| New patient visit (45+ min) | 82 | $12,196 | $149 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 593 | $9,125 | $15 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 29 | $7,585 | $262 |
| Short return visit (20+ min) | 92 | $6,196 | $59 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,369 | $447 |
| Programming of dual lead pacemaker system | 79 | $5,114 | $52 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 167 | $4,968 | $26 |
| New patient visit (60+ min) | 23 | $4,174 | $181 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,756 | $179 |
| Hospital observation care on day of discharge | 55 | $3,575 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 360 | $3,080 | $7 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 36 | $2,874 | $80 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 27 | $2,532 | $90 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 43 | $2,482 | $56 |
| External ekg recording for more than 48 hours up to 21 days | 84 | $2,373 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 74 | $2,313 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 84 | $2,096 | $24 |
| Long return visit (40+ min) | 15 | $1,857 | $124 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 50 | $1,806 | $32 |
| External shock to heart to regulate heart beat | 16 | $1,712 | $101 |
| Programming of multiple lead implantable defibrillator system | 16 | $1,641 | $86 |
| Programming of dual lead implantable defibrillator system | 15 | $1,390 | $69 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 22 | $1,097 | $50 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $1,077 | $60 |
| Programming of single lead pacemaker system | 16 | $871 | $44 |
| Programming of dual lead pacemaker system | 21 | $837 | $33 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $383 | $21 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 13 | $308 | $11 |
2016: 31 services
| Return visit (30+ min) | 202 | $40,023 | $92 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 33 | $21,971 | $610 |
| New patient visit (60+ min) | 72 | $12,927 | $180 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 50 | $12,396 | $234 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $9,122 | $570 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $8,180 | $234 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 516 | $7,805 | $15 |
| Programming of dual lead pacemaker system | 81 | $6,250 | $52 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $5,142 | $467 |
| Short return visit (20+ min) | 73 | $4,743 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 133 | $4,174 | $26 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 11 | $3,523 | $271 |
| Hospital observation care on day of discharge | 47 | $3,293 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,064 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 316 | $2,907 | $8 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 31 | $2,540 | $82 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 31 | $2,440 | $72 |
| New patient visit (45+ min) | 16 | $2,373 | $148 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 59 | $2,249 | $34 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 66 | $2,134 | $28 |
| Programming of dual lead implantable defibrillator system | 15 | $1,947 | $75 |
| External shock to heart to regulate heart beat | 13 | $1,670 | $111 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 25 | $1,543 | $57 |
| Programming of heart rhythm stimulation after drug infusion | 14 | $1,465 | $105 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 16 | $1,280 | $80 |
| External ekg recording for more than 48 hours up to 21 days | 46 | $1,277 | $27 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 46 | $1,123 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,029 | $64 |
| Programming of single lead pacemaker system | 15 | $945 | $47 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $841 | $56 |
| Programming of dual lead pacemaker system | 23 | $836 | $35 |
2015: 30 services
| Return visit (30+ min) | 220 | $50,135 | $99 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 33 | $27,093 | $774 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 50 | $14,768 | $279 |
| New patient visit (60+ min) | 68 | $13,038 | $192 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $10,198 | $637 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 33 | $10,156 | $290 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 600 | $9,915 | $16 |
| Programming of dual lead pacemaker system | 83 | $7,639 | $57 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,881 | $490 |
| Short return visit (20+ min) | 62 | $5,101 | $67 |
| Long return visit (40+ min) | 30 | $4,209 | $140 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 33 | $3,540 | $101 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 91 | $3,008 | $27 |
| Hospital observation care on day of discharge | 37 | $2,691 | $69 |
| Programming of dual lead implantable defibrillator system | 17 | $2,524 | $76 |
| External shock to heart to regulate heart beat | 17 | $2,324 | $116 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 56 | $2,274 | $36 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $2,262 | $87 |
| External ekg recording for more than 48 hours up to 21 days | 77 | $2,238 | $29 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 77 | $1,929 | $25 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,913 | $87 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 18 | $1,658 | $92 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 48 | $1,520 | $29 |
| Programming of heart rhythm stimulation after drug infusion | 13 | $1,405 | $108 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $1,294 | $65 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $1,143 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,087 | $68 |
| Programming of single lead pacemaker system | 12 | $1,029 | $47 |
| Programming of dual lead pacemaker system | 15 | $586 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 44 | $401 | $8 |
2014: 28 services
| Return visit (30+ min) | 161 | $31,147 | $91 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 28 | $14,212 | $490 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 50 | $12,356 | $242 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 43 | $9,234 | $205 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,197 | $586 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 556 | $8,027 | $14 |
| Long return visit (40+ min) | 57 | $7,293 | $128 |
| Programming of dual lead pacemaker system | 71 | $6,007 | $52 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,915 | $455 |
| Short return visit (20+ min) | 71 | $5,741 | $62 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 28 | $5,331 | $184 |
| Extended office or other outpatient service, first hour | 50 | $4,499 | $90 |
| New patient visit (60+ min) | 25 | $4,499 | $180 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 103 | $2,995 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $2,632 | $75 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 27 | $1,782 | $64 |
| External shock to heart to regulate heart beat | 15 | $1,767 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,729 | $62 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 55 | $1,608 | $25 |
| Hospital observation care on day of discharge | 20 | $1,435 | $65 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 16 | $1,295 | $76 |
| Programming of dual lead implantable defibrillator system | 13 | $1,222 | $72 |
| Programming of single lead pacemaker system | 15 | $973 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 15 | $964 | $64 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 17 | $958 | $48 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $821 | $33 |
| Programming of dual lead pacemaker system | 15 | $660 | $35 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 22 | $174 | $7 |
2013: 25 services
| Return visit (30+ min) | 147 | $27,788 | $91 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 76 | $8,956 | $83 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $8,126 | $625 |
| Long return visit (40+ min) | 61 | $8,048 | $130 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 462 | $7,733 | $16 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $7,368 | $433 |
| Programming of dual lead pacemaker system | 78 | $5,975 | $50 |
| Short return visit (20+ min) | 73 | $5,265 | $63 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 23 | $5,225 | $227 |
| New patient visit (60+ min) | 27 | $4,896 | $181 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 109 | $3,332 | $26 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 12 | $2,917 | $243 |
| Extended office or other outpatient service, first hour | 26 | $2,273 | $87 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 60 | $1,833 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,830 | $61 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $1,648 | $55 |
| Programming of dual lead implantable defibrillator system | 13 | $1,568 | $75 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 63 | $990 | $14 |
| Programming of single lead pacemaker system | 16 | $981 | $45 |
| Hospital observation care on day of discharge | 14 | $957 | $64 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 27 | $937 | $35 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $718 | $55 |
| Blood test, clotting time | 91 | $566 | $5 |
| Programming of dual lead pacemaker system | 14 | $463 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $153 | $13 |
Medicaid work
$2,380 in 2024
Medicaid paid $2,380 for 379 billed services this clinician did in 2024, up to 91 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 303 | $1,639 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 47 | $501 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 29 | $240 |
| 2024 | 379 | 3 | 91 | $2,380 |
| 2023 | 242 | 1 | 107 | $1,135 |
| 2022 | 406 | 1 | 85 | $2,475 |
| 2021 | 176 | 1 | 84 | $704 |
| 2020 | 200 | 1 | 61 | $1,554 |
| 2019 | 237 | 1 | 77 | $1,001 |
| 2018 | 141 | 1 | 63 | $794 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 242 | $1,135 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 406 | $2,475 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 176 | $704 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 200 | $1,554 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 237 | $1,001 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 141 | $794 |
Drugs they prescribed that Part D paid
$971,484
Pharmacies billed $971,484 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,204) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
1,454 generic and 750 brand-name prescriptions · $971,484 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 592 | $768,456 | $1,298 |
| Xarelto | 120 | $150,441 | $1,254 |
| Diltiazem 24hr Er (Cd) | 171 | $7,514 | $44 |
| Metoprolol | 377 | $7,212 | $19 |
| Dabigatran Etexilate | 16 | $6,856 | $429 |
See all 21 drugs
| Eliquis | 592 | $768,456 | $1,298 |
| Xarelto | 120 | $150,441 | $1,254 |
| Diltiazem 24hr Er (Cd) | 171 | $7,514 | $44 |
| Metoprolol | 377 | $7,212 | $19 |
| Dabigatran Etexilate | 16 | $6,856 | $429 |
| Flecainide Acetate | 155 | $6,851 | $44 |
| Amiodarone | 81 | $1,015 | $13 |
| Digoxin | 43 | $756 | $18 |
| Lisinopril | 84 | $719 | $9 |
| Atorvastatin | 61 | $492 | $8 |
| Potassium Chloride | 30 | $434 | $14 |
| Pantoprazole | 45 | $357 | $8 |
| Atenolol | 24 | $353 | $15 |
| Carvedilol | 51 | $347 | $7 |
| Metoprolol | 43 | $320 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $244 | $20 |
| Losartan | 25 | $211 | $8 |
| Amlodipine Besylate | 46 | $161 | $4 |
| Hydrochlorothiazide | 20 | $158 | $8 |
| Warfarin | 26 | $132 | $5 |
| Furosemide | 30 | $115 | $4 |
Year by year
| 2024 | 2,204 | 371 | 0% (0) | 34% | $971,484 |
| 2023 | 1,927 | 353 | 0% (0) | 32% | $786,952 |
| 2022 | 1,873 | 318 | 0% (0) | 29% | $684,134 |
| 2021 | 1,664 | 279 | 0% (0) | 32% | $567,519 |
| 2020 | 1,560 | 240 | 0% (0) | 33% | $466,697 |
| 2019 | 1,472 | 216 | 0% (0) | 36% | $420,088 |
| 2018 | 1,415 | 220 | 0% (0) | 30% | $308,454 |
| 2017 | 1,308 | 187 | 0% (0) | 35% | $236,569 |
| 2016 | 1,131 | 153 | None | 31% | $158,235 |
| 2015 | 985 | 148 | 0% (0) | 31% | $127,319 |
| 2014 | 879 | 120 | None | 33% | $104,651 |
| 2013 | 741 | 106 | None | 27% | $79,410 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Eliquis | 447 | $554,495 | $1,240 |
| Xarelto | 127 | $165,420 | $1,303 |
| Diltiazem 24hr Er (Cd) | 195 | $15,637 | $80 |
| Flecainide Acetate | 120 | $8,970 | $75 |
| Metoprolol | 321 | $8,557 | $27 |
| Digoxin | 38 | $1,588 | $42 |
| Diltiazem 24hr Er (Xr) | 23 | $1,438 | $63 |
| Amiodarone | 65 | $1,383 | $21 |
| Propafenone | 14 | $1,012 | $72 |
| Lisinopril | 65 | $906 | $14 |
| Diltiazem 24hr Er | 21 | $854 | $41 |
| Atorvastatin | 48 | $782 | $16 |
| Atenolol | 19 | $538 | $28 |
| Carvedilol | 50 | $426 | $9 |
| Warfarin | 34 | $380 | $11 |
| Potassium Chloride | 23 | $371 | $16 |
| Metoprolol | 34 | $355 | $10 |
| Pantoprazole | 53 | $332 | $6 |
| Amlodipine Besylate | 43 | $259 | $6 |
| Losartan | 13 | $238 | $18 |
| Triamterene-Hydrochlorothiazid | 13 | $228 | $18 |
| Furosemide | 19 | $185 | $10 |
| Hydrochlorothiazide | 14 | $45 | $3 |
2022: 21 drugs
| Eliquis | 387 | $455,426 | $1,177 |
| Xarelto | 116 | $147,966 | $1,276 |
| Diltiazem 24hr Er (Cd) | 178 | $18,454 | $104 |
| Flecainide Acetate | 134 | $9,976 | $74 |
| Metoprolol | 337 | $7,916 | $23 |
| Amiodarone | 71 | $2,483 | $35 |
| Diltiazem | 12 | $1,582 | $132 |
| Atorvastatin | 58 | $946 | $16 |
| Carvedilol | 47 | $907 | $19 |
| Dilt-Xr | 14 | $833 | $59 |
| Digoxin | 26 | $705 | $27 |
| Lisinopril | 86 | $667 | $8 |
| Atenolol | 20 | $660 | $33 |
| Losartan | 25 | $505 | $20 |
| Amlodipine Besylate | 60 | $367 | $6 |
| Warfarin | 22 | $334 | $15 |
| Potassium Chloride | 14 | $314 | $22 |
| Pantoprazole | 37 | $280 | $8 |
| Metoprolol | 26 | $212 | $8 |
| Furosemide | 37 | $167 | $5 |
| Hydrochlorothiazide | 16 | $71 | $4 |
2021: 26 drugs
| Eliquis | 355 | $350,102 | $986 |
| Xarelto | 111 | $132,888 | $1,197 |
| Pradaxa | 17 | $17,714 | $1,042 |
| Diltiazem 24hr Er (Cd) | 131 | $13,681 | $104 |
| Multaq | 13 | $10,878 | $837 |
| Flecainide Acetate | 103 | $10,856 | $105 |
| Metoprolol | 282 | $7,541 | $27 |
| Amiodarone | 80 | $2,537 | $32 |
| Propafenone | 14 | $2,335 | $167 |
| Diltiazem | 14 | $1,403 | $100 |
| Olmesartan Medoxomil | 11 | $1,399 | $127 |
| Cartia Xt | 11 | $974 | $89 |
| Digoxin | 23 | $872 | $38 |
| Dilt-Xr | 16 | $780 | $49 |
| Carvedilol | 43 | $730 | $17 |
| Atorvastatin | 41 | $729 | $18 |
| Atenolol | 22 | $566 | $26 |
| Warfarin | 25 | $548 | $22 |
| Lisinopril | 60 | $394 | $7 |
| Amlodipine Besylate | 50 | $316 | $6 |
| Losartan | 17 | $313 | $18 |
| Pantoprazole | 35 | $279 | $8 |
| Potassium Chloride | 13 | $262 | $20 |
| Furosemide | 24 | $139 | $6 |
| Metoprolol | 32 | $125 | $4 |
| Hydrochlorothiazide | 14 | $38 | $3 |
2020: 22 drugs
| Eliquis | 331 | $273,055 | $825 |
| Xarelto | 91 | $111,618 | $1,227 |
| Pradaxa | 23 | $18,217 | $792 |
| Diltiazem 24hr Er (Cd) | 134 | $14,766 | $110 |
| Flecainide Acetate | 91 | $9,494 | $104 |
| Metoprolol | 271 | $8,653 | $32 |
| Multaq | 12 | $8,438 | $703 |
| Amiodarone | 68 | $2,448 | $36 |
| Propafenone | 23 | $2,357 | $102 |
| Dilt-Xr | 11 | $996 | $91 |
| Carvedilol | 57 | $708 | $12 |
| Warfarin | 32 | $598 | $19 |
| Potassium Chloride | 26 | $561 | $22 |
| Lisinopril | 69 | $430 | $6 |
| Atenolol | 29 | $383 | $13 |
| Losartan | 21 | $357 | $17 |
| Atorvastatin | 19 | $282 | $15 |
| Amlodipine Besylate | 35 | $271 | $8 |
| Pantoprazole | 25 | $201 | $8 |
| Metoprolol | 23 | $120 | $5 |
| Furosemide | 26 | $109 | $4 |
| Hydrochlorothiazide | 15 | $59 | $4 |
2019: 27 drugs
| Eliquis | 322 | $224,424 | $697 |
| Xarelto | 111 | $115,511 | $1,041 |
| Pradaxa | 29 | $17,128 | $591 |
| Diltiazem 24hr Er (Cd) | 123 | $15,608 | $127 |
| Multaq | 12 | $8,447 | $704 |
| Metoprolol | 225 | $8,441 | $38 |
| Flecainide Acetate | 75 | $6,412 | $85 |
| Amiodarone | 52 | $2,713 | $52 |
| Propafenone | 20 | $2,276 | $114 |
| Diltiazem 24hr Er | 33 | $1,863 | $56 |
| Diltiazem | 19 | $1,187 | $62 |
| Cartia Xt | 21 | $830 | $40 |
| Potassium Chloride | 31 | $775 | $25 |
| Carvedilol | 39 | $496 | $13 |
| Losartan | 16 | $431 | $27 |
| Lisinopril | 60 | $428 | $7 |
| Olmesartan Medoxomil | 11 | $414 | $38 |
| Atorvastatin | 25 | $389 | $16 |
| Warfarin | 22 | $377 | $17 |
| Amlodipine Besylate | 46 | $308 | $7 |
| Metoprolol | 22 | $163 | $7 |
| Furosemide | 20 | $152 | $8 |
| Simvastatin | 15 | $116 | $8 |
| Pantoprazole | 13 | $90 | $7 |
| Omeprazole | 13 | $72 | $6 |
| Tamsulosin | 12 | $69 | $6 |
| Hydrochlorothiazide | 12 | $38 | $3 |
2018: 23 drugs
| Eliquis | 231 | $157,123 | $680 |
| Xarelto | 88 | $74,131 | $842 |
| Pradaxa | 37 | $15,988 | $432 |
| Multaq | 18 | $15,739 | $874 |
| Metoprolol | 225 | $9,366 | $42 |
| Flecainide Acetate | 102 | $7,259 | $71 |
| Diltiazem 24hr Er (Cd) | 77 | $6,349 | $82 |
| Amiodarone | 67 | $3,013 | $45 |
| Propafenone | 15 | $1,683 | $112 |
| Cartia Xt | 40 | $1,593 | $40 |
| Diltiazem 24hr Er | 23 | $1,145 | $50 |
| Atorvastatin | 18 | $695 | $39 |
| Potassium Chloride | 31 | $683 | $22 |
| Carvedilol | 67 | $519 | $8 |
| Lisinopril | 80 | $461 | $6 |
| Warfarin | 24 | $456 | $19 |
| Amlodipine Besylate | 44 | $206 | $5 |
| Metoprolol | 33 | $198 | $6 |
| Omeprazole | 25 | $194 | $8 |
| Simvastatin | 29 | $130 | $4 |
| Atenolol | 12 | $78 | $6 |
| Furosemide | 12 | $73 | $6 |
| Hydrochlorothiazide | 18 | $63 | $4 |
2017: 26 drugs
| Eliquis | 176 | $99,336 | $564 |
| Xarelto | 108 | $64,190 | $594 |
| Pradaxa | 37 | $22,839 | $617 |
| Multaq | 21 | $12,401 | $591 |
| Propafenone Hcl Er | 18 | $9,039 | $502 |
| Metoprolol | 184 | $7,820 | $42 |
| Flecainide Acetate | 63 | $4,038 | $64 |
| Diltiazem 24hr Er | 59 | $2,718 | $46 |
| Propafenone | 39 | $2,243 | $58 |
| Cartia Xt | 40 | $2,013 | $50 |
| Amiodarone | 64 | $1,335 | $21 |
| Pravastatin | 12 | $831 | $69 |
| Warfarin | 38 | $594 | $16 |
| Lisinopril | 90 | $544 | $6 |
| Atorvastatin | 28 | $358 | $13 |
| Carvedilol | 39 | $287 | $7 |
| Potassium Chloride | 17 | $284 | $17 |
| Losartan | 13 | $240 | $18 |
| Metoprolol | 36 | $199 | $6 |
| Clopidogrel | 11 | $150 | $14 |
| Amlodipine Besylate | 27 | $137 | $5 |
| Simvastatin | 23 | $113 | $5 |
| Atenolol | 18 | $110 | $6 |
| Omeprazole | 19 | $108 | $6 |
| Furosemide | 25 | $79 | $3 |
| Hydrochlorothiazide | 25 | $40 | $2 |
2016: 25 drugs
| Eliquis | 111 | $53,351 | $481 |
| Xarelto | 107 | $51,214 | $479 |
| Multaq | 23 | $13,913 | $605 |
| Pradaxa | 16 | $9,247 | $578 |
| Metoprolol | 161 | $5,491 | $34 |
| Diltiazem 24hr Er | 64 | $5,104 | $80 |
| Flecainide Acetate | 72 | $2,990 | $42 |
| Propafenone | 52 | $1,680 | $32 |
| Amiodarone | 65 | $1,473 | $23 |
| Cartia Xt | 25 | $813 | $33 |
| Warfarin | 58 | $663 | $11 |
| Pravastatin | 11 | $547 | $50 |
| Verapamil Er | 11 | $485 | $44 |
| Atorvastatin | 30 | $382 | $13 |
| Losartan | 17 | $274 | $16 |
| Lisinopril | 35 | $258 | $7 |
| Carvedilol | 28 | $198 | $7 |
| Metoprolol | 37 | $176 | $5 |
| Amlodipine Besylate | 24 | $156 | $7 |
| Atenolol | 19 | $121 | $6 |
| Isosorbide Mononitrate Er | 12 | $107 | $9 |
| Simvastatin | 22 | $77 | $3 |
| Omeprazole | 11 | $70 | $6 |
| Furosemide | 14 | $43 | $3 |
| Hydrochlorothiazide | 22 | $41 | $2 |
2015: 24 drugs
| Xarelto | 136 | $61,758 | $454 |
| Eliquis | 45 | $17,090 | $380 |
| Pradaxa | 15 | $9,419 | $628 |
| Multaq | 15 | $7,390 | $493 |
| Diltiazem 24hr Er | 54 | $4,978 | $92 |
| Metoprolol | 116 | $4,928 | $42 |
| Flecainide Acetate | 47 | $2,234 | $48 |
| Amiodarone | 40 | $1,278 | $32 |
| Warfarin | 80 | $1,098 | $14 |
| Propafenone | 31 | $688 | $22 |
| Atorvastatin | 29 | $629 | $22 |
| Pravastatin | 11 | $621 | $56 |
| Verapamil Er | 13 | $480 | $37 |
| Carvedilol | 36 | $319 | $9 |
| Atenolol | 34 | $212 | $6 |
| Lisinopril | 37 | $190 | $5 |
| Metoprolol | 33 | $188 | $6 |
| Potassium Chloride | 12 | $171 | $14 |
| Furosemide | 21 | $120 | $6 |
| Amlodipine Besylate | 32 | $99 | $3 |
| Omeprazole | 15 | $89 | $6 |
| Sotalol | 12 | $77 | $6 |
| Hydrochlorothiazide | 19 | $51 | $3 |
| Simvastatin | 12 | $48 | $4 |
2014: 22 drugs
| Xarelto | 151 | $54,057 | $358 |
| Pradaxa | 40 | $13,370 | $334 |
| Propafenone Hcl Er | 11 | $7,527 | $684 |
| Metoprolol | 66 | $4,216 | $64 |
| Diltiazem 24hr Er | 44 | $2,848 | $65 |
| Enoxaparin | 12 | $1,937 | $161 |
| Flecainide Acetate | 33 | $1,241 | $38 |
| Atorvastatin | 34 | $794 | $23 |
| Pravastatin | 12 | $767 | $64 |
| Amiodarone | 47 | $661 | $14 |
| Carvedilol | 47 | $581 | $12 |
| Warfarin | 49 | $516 | $11 |
| Verapamil Er | 14 | $417 | $30 |
| Atenolol | 29 | $286 | $10 |
| Lisinopril | 50 | $255 | $5 |
| Potassium Chloride | 14 | $224 | $16 |
| Sotalol | 11 | $221 | $20 |
| Amlodipine Besylate | 31 | $199 | $6 |
| Furosemide | 37 | $127 | $3 |
| Metoprolol | 14 | $107 | $8 |
| Omeprazole | 11 | $87 | $8 |
| Simvastatin | 14 | $58 | $4 |
2013: 18 drugs
| Xarelto | 63 | $21,406 | $340 |
| Pradaxa | 52 | $20,938 | $403 |
| Propafenone | 33 | $13,223 | $401 |
| Enoxaparin | 15 | $3,479 | $232 |
| Diltiazem 24hr Er | 50 | $3,390 | $68 |
| Diovan | 15 | $3,060 | $204 |
| Metoprolol | 54 | $2,839 | $53 |
| Diltiazem 24hr Cd | 20 | $2,782 | $139 |
| Flecainide Acetate | 23 | $1,442 | $63 |
| Carvedilol | 42 | $647 | $15 |
| Atorvastatin | 19 | $587 | $31 |
| Warfarin | 53 | $516 | $10 |
| Amiodarone | 35 | $505 | $14 |
| Atenolol | 41 | $487 | $12 |
| Lisinopril | 51 | $334 | $7 |
| Digox | 18 | $172 | $10 |
| Furosemide | 27 | $105 | $4 |
| Amlodipine Besylate | 18 | $99 | $5 |
Money from drug and device companies
$826 in 2025
| 2025 | 6 | 18 | None | $826 |
| 2024 | 5 | 10 | None | $375 |
| 2023 | 4 | 4 | None | $200 |
| 2022 | 2 | 6 | None | $223 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 1 | 1 | None | $21 |
| 2019 | 4 | 7 | $2,400 | $2,677 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Synergy Ablation System | $321 | 2 payments
|
| Biosense Webster | Carto 3 | $155 | 6 payments
|
| Medtronic | Selectsecure | $150 | 2 payments
|
| Abbott Laboratories | Ensite Precision | $140 | 6 payments
|
| Boston Scientific | Farapulse | $33 | 1 payment
|
| Terumo Medical | Navicross | $27 | 1 payment
|
See all 18 published payments
| Abbott Laboratories | Meals · 2025-12-28 | Workmate Claris | $24 |
| Boston Scientific | Meals · 2025-12-15 | Farapulse | $33 |
| Abbott Laboratories | Meals · 2025-12-15 | Ensite | $24 |
| Abbott Laboratories | Meals · 2025-10-22 | Ensite Precision | $24 |
| Abbott Laboratories | Meals · 2025-10-22 | Ensite | $21 |
| Biosense Webster | Meals · 2025-10-09 | Carto 3 | $27 |
| AtriCure | Meals · 2025-09-18 | Synergy Ablation System | $186 |
| Abbott Laboratories | Meals · 2025-09-09 | Ensite Precision | $23 |
| Abbott Laboratories | Meals · 2025-09-09 | Triclip | $24 |
| Medtronic | Meals · 2025-08-15 | Cobalt Dr Mri Surescan | $57 |
| Biosense Webster | Meals · 2025-07-23 | Carto 3 | $33 |
| Biosense Webster | Meals · 2025-05-19 | Carto 3 | $22 |
| Biosense Webster | Meals · 2025-05-16 | Carto 3 | $30 |
| Biosense Webster | Meals · 2025-05-01 | Carto 3 | $22 |
| Medtronic | Meals · 2025-04-23 | Selectsecure | $93 |
| Terumo Medical | Meals · 2025-03-26 | Navicross | $27 |
| AtriCure | Meals · 2025-03-20 | Epi-Sense Guided Coagulation System With Visitrax | $136 |
| Biosense Webster | Meals · 2025-03-04 | Carto 3 | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $375
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $149 | 1 payment
|
| Biosense Webster | Carto 3 | $126 | 4 payments
|
| Abbott Laboratories | Ensite | $44 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $31 | 2 payments
|
| Penumbra | Indigo System | $26 | 1 payment
|
2023: $200
| Biosense Webster | Qdot Micro Catheter | $137 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $26 | 1 payment
|
| Terumo Medical | Glidesheath Slender | $22 | 1 payment
|
| Merit Medical Systems | Aspire Home Drainage Catheter | $16 | 1 payment
|
2022: $223
| Biosense Webster | Carto 3 | $180 | 4 payments
|
| Abbott Laboratories | Vantageview | $43 | 2 payments
|
2021: $17
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $17 | 1 payment
|
2020: $21
| Abbott Laboratories | Viewflex Xtra Ice Catheter | $21 | 1 payment
|
2019: $2,677
| Medical Device Business Services | Carto 3 System | $2,400 | 2 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $194 | 2 payments
|
| Medtronic Vascular | Azure | $69 | 2 payments
|
| Biosense Webster | Carto 3 System | $14 | 1 payment
|
Professional record
- NPI
- 1689604241
- Licence
- CA A68634California A68634: Current · expires 2027-06-30
- Trained
- Js Weill Medical College, Cornell University, 1991
- Group
- Sutter Bay Medical Foundation · Physician Services at El Camino Hospital · Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-07-03
- NPI last updated
- 2020-05-28
- NPI record certified
- 2020-05-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301